<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000566" GROUP_ID="INJ" ID="580799072011522175" MERGED_FROM="" MODIFIED="2009-05-12 17:52:06 +0200" MODIFIED_BY="Emma Sydenham" REVIEW_NO="002" REVMAN_SUB_VERSION="5.0.20" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="9.0">
<COVER_SHEET MODIFIED="2009-05-12 17:52:06 +0200" MODIFIED_BY="Emma Sydenham">
<TITLE>Hyperventilation therapy for acute traumatic brain injury</TITLE>
<CONTACT MODIFIED="2009-05-12 17:52:06 +0200" MODIFIED_BY="Emma Sydenham"><PERSON ID="8053" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Ian</FIRST_NAME><LAST_NAME>Roberts</LAST_NAME><POSITION>Professor of Epidemiology &amp; Public Health</POSITION><EMAIL_1>ian.roberts@lshtm.ac.uk</EMAIL_1><URL>http://injuries.cochrane.org</URL><ADDRESS><DEPARTMENT>Cochrane Injuries Group</DEPARTMENT><ORGANISATION>London School of Hygiene &amp; Tropical Medicine</ORGANISATION><ADDRESS_1>North Courtyard</ADDRESS_1><ADDRESS_2>Keppel Street</ADDRESS_2><CITY>London</CITY><ZIP>WC1E 7HT</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 20 7958 8128</PHONE_1><FAX_1>+44 20 7299 4663</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2009-05-12 17:52:06 +0200" MODIFIED_BY="Emma Sydenham"><PERSON ID="8053" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Ian</FIRST_NAME><LAST_NAME>Roberts</LAST_NAME><POSITION>Professor of Epidemiology &amp; Public Health</POSITION><EMAIL_1>ian.roberts@lshtm.ac.uk</EMAIL_1><URL>http://injuries.cochrane.org</URL><ADDRESS><DEPARTMENT>Cochrane Injuries Group</DEPARTMENT><ORGANISATION>London School of Hygiene &amp; Tropical Medicine</ORGANISATION><ADDRESS_1>North Courtyard</ADDRESS_1><ADDRESS_2>Keppel Street</ADDRESS_2><CITY>London</CITY><ZIP>WC1E 7HT</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 20 7958 8128</PHONE_1><FAX_1>+44 20 7299 4663</FAX_1></ADDRESS></PERSON><PERSON ID="14465" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Gillian</FIRST_NAME><LAST_NAME>Schierhout</LAST_NAME><EMAIL_1>gillsch@mweb.co.za</EMAIL_1><ADDRESS><DEPARTMENT>c/o Cochrane Injuries Group</DEPARTMENT><ORGANISATION>London School of Hygiene &amp; Tropical Medicine</ORGANISATION><ADDRESS_1>Keppel Street</ADDRESS_1><CITY>London</CITY><ZIP>WC1E 7HT</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2009-05-05 15:49:15 +0100" MODIFIED_BY="Emma M Sydenham">
<UP_TO_DATE>
<DATE DAY="7" MONTH="1" YEAR="2008"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="7" MONTH="1" YEAR="2008"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="13" MONTH="7" YEAR="2011"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="1997"/>
<REVIEW_PUBLISHED ISSUE="4" YEAR="1997"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="1997"/>
</DATES>
<WHATS_NEW MODIFIED="2009-05-05 15:50:27 +0100" MODIFIED_BY="Emma M Sydenham">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2009-05-05 15:50:27 +0100" MODIFIED_BY="Emma M Sydenham">
<DATE DAY="5" MONTH="5" YEAR="2009"/>
<DESCRIPTION>
<P>The search was updated to January 2008. No new trials were identified. The conclusions remain the same.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2009-05-05 15:49:22 +0100" MODIFIED_BY="Emma M Sydenham">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-05-05 15:49:22 +0100" MODIFIED_BY="Emma M Sydenham">
<DATE DAY="9" MONTH="6" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-06-09 23:23:54 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="8" MONTH="3" YEAR="2006"/>
<DESCRIPTION>
<P>The search was last updated in March 2006; no additional eligible studies were identified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2009-05-12 16:50:38 +0100" MODIFIED_BY="Emma M Sydenham">
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES MODIFIED="2009-05-12 16:50:38 +0100" MODIFIED_BY="Emma M Sydenham">
<SOURCE MODIFIED="2009-05-12 16:50:38 +0100" MODIFIED_BY="Emma M Sydenham">
<NAME>NHS R&amp;D Programme: Mother and Child Health</NAME>
<COUNTRY CODE="GB">UK</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2009-05-12 16:49:09 +0100" MODIFIED_BY="Emma M Sydenham">
<SUMMARY MODIFIED="2009-05-12 16:41:30 +0100" MODIFIED_BY="Emma M Sydenham">
<TITLE>Not enough evidence on whether hyperventilation therapy improves outcomes for people with traumatic brain injury</TITLE>
<SUMMARY_BODY MODIFIED="2009-05-12 16:41:30 +0100" MODIFIED_BY="Emma M Sydenham">
<P>Traumatic brain injury is a major cause of premature death and disability. Severe head injury can trigger brain swelling, thereby increasing pressure on the brain (raised intracranial pressure, ICP). Raised ICP increases the likelihood of brain damage or death. Treatment to lower people's ICP commonly involves hyperventilation therapy (increasing blood oxygen levels) following the brain injury. While hyperventilation therapy can reduce ICP after traumatic brain injury, the review of trials found there is no strong evidence about whether this improves outcomes. More trials are needed.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2009-05-12 16:41:14 +0100" MODIFIED_BY="Emma M Sydenham">
<ABS_BACKGROUND>
<P>Because hyperventilation is often associated with a rapid fall in intracranial pressure, it has been assumed to be effective in the treatment of severe head injury. Hyperventilation reduces raised intracranial pressure by causing cerebral vasoconstriction and a reduction in cerebral blood flow. Whether or not reduced cerebral blood flow improves neurological outcome is, however, unclear.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>To quantify the effect of hyperventilation on death and neurological disability following head injury.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2009-05-12 16:41:14 +0100" MODIFIED_BY="Emma M Sydenham">
<P>We searched the following electronic databases: the Cochrane Injuries Group Specialised Register, CENTRAL (<I>The Cochrane Library</I> 2007, Issue 4), MEDLINE, PubMed, EMBASE, PsycINFO. We searched the Internet, checked reference lists of relevant studies, and contacted the first author of eligible reports to ask for assistance in identifying any further trials. The searches were updated in January 2008.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>All randomised trials of hyperventilation, in which study participants had a clinically defined acute traumatic head injury of any severity. There were no language restrictions.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION>
<P>We collected data on the participants, the timing and duration of the intervention, duration of follow-up, neurological disability and death. Relative risks (RR) and 95% confidence intervals (CI) were calculated for each trial on an intention-to-treat basis. Timing, degree and duration of hyperventilation were identified a-priori as potential sources of heterogeneity between trials.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS>
<P>One trial of 113 participants was identified. Hyperventilation alone, as well as in conjunction with a buffer (THAM [tris-hydroxy-methyl-amino methane]), showed a beneficial effect on mortality at one year after injury, although the effect measure was imprecise (RR 0.73; 95% CI 0.36 to 1.49, and RR 0.89; 95% CI 0.47 to 1.72 respectively). This improvement in outcome was not supported by an improvement in neurological recovery. For hyperventilation alone, the RR for death or severe disability was 1.14 (95% CI 0.82 to 1.58). The RR for death or severe disability in the hyperventilation-plus-THAM group was 0.87 (95% CI 0.58 to 1.28).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS>
<P>The data available are inadequate to assess any potential benefit or harm that might result from hyperventilation in severe head injury. Randomised controlled trials to assess the effectiveness of hyperventilation therapy following severe head injury are needed.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2009-05-12 16:49:01 +0100" MODIFIED_BY="Emma M Sydenham">
<BACKGROUND MODIFIED="2009-05-12 16:42:37 +0100" MODIFIED_BY="Emma M Sydenham">
<P>There are at least 10 million new head injuries each year, of which thousands will result in death or long term disability (<LINK REF="REF-Alexander-1992" TYPE="REFERENCE">Alexander 1992</LINK>). Hyperventilation has been widely used in the treatment and prevention of raised intracranial pressure (ICP) following head injury. It is a simple practicable intervention in many centres. A 1995 survey of the critical care management of head injured patients in the United States showed that 83% of centres used hyperventilation in more than half of severely head injured patients with 29% of centres aiming for a target partial pressure of arterial carbon dioxide (PaCO<SUB>2</SUB>) of less than 3.3kPa (<LINK REF="REF-Ghajar-1995" TYPE="REFERENCE">Ghajar 1995</LINK>). A survey in the United Kingdom showed that 100% of neurosurgical centres use hyperventilation in the treatment of raised intracranial pressure, although in contrast to the North American centres, far fewer UK units aim for very low levels of CO<SUB>2</SUB>, with only 3% of units aiming for a PaCO<SUB>2</SUB> of 3.3kPa or less (<LINK REF="REF-Jeevaratnam-1996" TYPE="REFERENCE">Jeevaratnam 1996</LINK>).</P>
<P>Hyperventilation to a PaCO<SUB>2</SUB> of 20 to 30mmHg during the first few days after head injury has been recommended widely (<LINK REF="REF-Becker-1985" TYPE="REFERENCE">Becker 1985</LINK>; <LINK REF="REF-Marshall-1987" TYPE="REFERENCE">Marshall 1987</LINK>). The original rationale for the use of hyperventilation following head injury was first described by <LINK REF="REF-Bruce-1981" TYPE="REFERENCE">Bruce 1981</LINK>. However, more recently, controversy has emerged as to the PaCO<SUB>2</SUB> that should be targeted in hyperventilation (<LINK REF="REF-Sheinberg-1992" TYPE="REFERENCE">Sheinberg 1992</LINK>), the timing (whether within the first five days after head injury), the duration of hyperventilation, and the indications (<LINK REF="REF-Marion-1995" TYPE="REFERENCE">Marion 1995</LINK>; <LINK REF="REF-Previgliano-1995" TYPE="REFERENCE">Previgliano 1995</LINK>; <LINK REF="REF-Rosner-1995" TYPE="REFERENCE">Rosner 1995</LINK>). Although hyperventilation produces a rapid reduction in ICP (intracranial pressure), and high or uncontrolled ICP is one of the most common precursors of death or neurological disability in traumatically brain injured patients, there is little evidence to suggest that reducing ICP through hyperventilation improves clinically relevant outcomes, and some pathophysiological explanations and the findings of a small randomised controlled trial have been used to suggest it may worsen outcome (<LINK REF="REF-Miller-1994" TYPE="REFERENCE">Miller 1994</LINK>). Recent recommendations by the task force of the United States Brain Trauma Foundation suggest that prophylactic hyperventilation (PaCO<SUB>2</SUB> &lt; 35mmHg) during the first 24 hours after brain injury should be avoided; the use of hyperventilation at any other stage after injury was acknowledged as an area of considerable clinical uncertainty (<LINK REF="REF-Task-force-1995" TYPE="REFERENCE">Task force 1995</LINK>).</P>
<P>To examine the effectiveness of hyperventilation on outcome, we conducted a systematic review of randomised controlled trials.</P>
</BACKGROUND>
<OBJECTIVES>
<P>To quantify the effect of hyperventilation on death and neurological disability in brain injured patients.</P>
<P>Timing, degree, and duration of hyperventilation and presence of raised ICP were factors identified a-priori as potential sources of heterogeneity between trials.</P>
</OBJECTIVES>
<METHODS MODIFIED="2009-05-12 16:45:52 +0100" MODIFIED_BY="Emma M Sydenham">
<SELECTION_CRITERIA>
<CRIT_STUDIES>
<P>The review included all randomised and quasi-randomised controlled trials of hyperventilation in which hyperventilation was compared to normo-ventilation.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Trials in which participants had a clinically defined brain injury of any severity.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>The experimental intervention was hyperventilation (PaCO<SUB>2</SUB> less than or equal to 35mmHg) at any time within eight weeks following injury.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES>
<P>We aimed to extract number of patients in the treatment and control groups who had died at the end of follow-up, who were in a vegetative state, severely disabled, moderately disabled or who had made a good recovery according to Glasgow Outcome Scale (GOS) criteria.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2009-05-12 16:43:22 +0100" MODIFIED_BY="Emma M Sydenham">
<P>The search was not restricted by language or publication status.</P>
<ELECTRONIC_SEARCHES MODIFIED="2009-05-12 16:43:22 +0100" MODIFIED_BY="Emma M Sydenham">
<P>We searched the following electronic databases;</P>
<UL>
<LI>CENTRAL (<I>The Cochrane Library</I> 2007, Issue 4);</LI>
<LI>MEDLINE (Ovid SP) 1950 to Nov (week 2) 2007;</LI>
<LI>PubMed [www.ncbi.nlm.nih.gov/sites/entrez/] (searched 7 Jan 2008: added to PubMed in the last 60 days);</LI>
<LI>EMBASE (Ovid SP) 1980 to (week 1) Jan 2008;</LI>
<LI>PsycINFO (Ovid SP) 1806 to April 2007;</LI>
</UL>
<P>The search strategy used for previous versions of this review can be found in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>. The searches used for this update can be found in <LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2008-06-09 23:25:59 +0100" MODIFIED_BY="[Empty name]">
<P>We also conducted a general Internet search and searched web-based trials databases.</P>
<P>The reference lists of all relevant articles identified were checked. A letter was sent to the first author of reports to ask for further information on the published report and asking them to assist in identifying any further trials which may have been conducted by them, or other investigators.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2009-05-12 16:45:52 +0100" MODIFIED_BY="Emma M Sydenham">
<DATA_EXTRACTION MODIFIED="2009-05-12 16:44:14 +0100" MODIFIED_BY="Emma M Sydenham">
<P>Both reviewers independently extracted data and then cross-checked the extracted data. Data on the number of patients with each outcome event were extracted according to treatment allocated, regardless of whether or not the patient was subsequently deemed ineligible for follow-up or treatment, in order to allow an 'intent-to-treat' analysis.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2009-05-12 16:45:52 +0100" MODIFIED_BY="Emma M Sydenham">
<P>Since there is evidence that the quality of allocation concealment particularly affects the results of studies (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>), both reviewers scored this quality on the scale used by Higgins (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>) as shown below, assigning 'No' to poorest quality and 'Yes' to best quality:<BR/>No = trials in which concealment was inadequate (such as alternation or reference to case record numbers or to dates of birth);<BR/>Unclear = trials in which the authors either did not report an allocation concealment approach at all or reported an approach that did not fall into one of the other categories;<BR/>Yes = trials deemed to have taken adequate measures to conceal allocation (i.e. central randomisation; numbered or coded bottles or containers; drugs prepared by the pharmacy; serially numbered, opaque, sealed envelopes; or other description that contained elements convincing of concealment).</P>
</QUALITY_ASSESSMENT>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2009-05-12 16:48:07 +0100" MODIFIED_BY="Emma M Sydenham">
<STUDY_DESCRIPTION MODIFIED="2009-05-12 16:47:00 +0100" MODIFIED_BY="Emma M Sydenham">
<P>One study meeting the inclusion criteria was identified (reported in <LINK REF="REF-Ward-1989" TYPE="REFERENCE">Ward 1989</LINK>; <LINK REF="STD-Muizelaar-1991" TYPE="STUDY">Muizelaar 1991</LINK> and <LINK REF="REF-Marmarou-1993" TYPE="REFERENCE">Marmarou 1993</LINK>). This study included patients with severe closed head injury (Glasgow Coma Scale (GCS) less than or equal to 8), three years of age or older, who had already received initial resuscitation, diagnosis and treatment for mass lesions. One hundred and thirteen patients with severe head injury were stratified into two groups according to the motor score of the GCS, and then randomised to a control group (n = 41), a hyperventilation group (n = 36), and a group which received hyperventilation plus a buffer (THAM [tris-hydroxy-methyl-amino methane]) (n = 36). Approximately 70% of the participants were male and most were young adults. All patients received standard care, which included monitoring of ICP, and the introduction of various ICP-lowering agents, such as mannitol and barbiturates. All patients were intubated and artificially ventilated. Not all patients necessarily had raised ICP at entry to the study; approximately 14% in each group had elevated ICP on admission.</P>
<P>The intervention in the hyperventilation and in the hyperventilation-plus-THAM group comprised adjusting the respiratory rate and the volume of the ventilator to keep PaCO<SUB>2</SUB> at 24 to 28mmHg. In addition, the hyperventilation-plus-THAM group received an initial dose of THAM calculated individually according to body weight and base deficit. This was followed by a constant infusion of THAM at 1ml/kg/hr for five days. Hyperventilation was maintained for five days.</P>
<P>The study authors presented outcomes of death, severe disability/vegetative state and good recovery/moderate disability at 3, 6 and 12 months stratified by motor score at time of entry. Follow up was 100%.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2009-05-12 16:48:07 +0100" MODIFIED_BY="Emma M Sydenham">
<P>The planned method of randomisation should have been adequate to prevent foreknowledge of treatment allocation; random number tables were used to generate randomisation, and two separate series of opaque envelopes related to the motor score were assigned to eligible patients. However the authors reported a departure from the proper method of randomisation, in that early on in the study, patients from whom informed consent could not be obtained immediately were assigned to the control group without drawing an envelope. This practice was stopped as soon as the trialist became aware of it. These patients could not be identified later.</P>
<P>The study was not double-blind in that the evaluator was not blind to the treatment given. Outcome was assessed by only one evaluator.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS>
<P>Hyperventilation alone, as well as in conjunction with the buffer THAM, showed a beneficial effect on mortality at a year after injury (RR 0.73; 95% CI 0.36 to 1.49 and RR 0.89; 95% CI 0.47 to 1.72 respectively). This improvement in outcome was not supported by an improvement in neurological recovery. For hyperventilation alone, the RR for death or severe disability was 1.14 (95% CI 0.82 to 1.58). The RR for death or severe disability for the hyperventilation-plus-THAM group was 0.87 (95% CI 0.58 to 1.28).</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>Owing to the small study size, all of the effect measures were imprecise. The findings of this small randomised controlled trial in severely head injured patients, not all of whom had raised ICP highlight the need for further randomised controlled trials to address the question of the appropriateness of this widely used intervention.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2009-05-12 16:49:01 +0100" MODIFIED_BY="Emma M Sydenham">
<IMPLICATIONS_PRACTICE MODIFIED="2009-05-12 16:48:46 +0100" MODIFIED_BY="Emma M Sydenham">
<P>The data available are insufficient to assess any potential benefit or harm that might result from hyperventilation in severe head injury.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2009-05-12 16:49:01 +0100" MODIFIED_BY="Emma M Sydenham">
<P>Further randomised controlled trials to asses the effectiveness of hyperventilation therapy following severe head injury are needed. The PaCO<SUB>2</SUB> that should be targeted in hyperventilation, the timing, duration, and whether or not the intervention has a net benefit in certain groups of patients, such as those with raised ICP, needs to be investigated.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS/>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2009-05-12 16:49:09 +0100" MODIFIED_BY="Emma M Sydenham">
<P>GS designed and ran the searches, screened the citations for eligibility, contacted authors, extracted data, entered data into RevMan and wrote the review. IR screened citations, extracted data and helped to write the review. IR updated the review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2009-05-12 16:49:34 +0100" MODIFIED_BY="Emma M Sydenham">
<STUDIES>
<INCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Muizelaar-1991" NAME="Muizelaar 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Marmarou A, Holdaway R, Ward JD, Yoshida K, Choi SC, Muizelaar JP, Young HF. Traumatic brain tissue acidosis : experimental and clinical studies. Acta-Neurochir-Suppl-Wein 57: 160-4.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marmarou A, Holdaway R, Ward JD, Yoshida K, Choi SC, Muizelaar JP et al</AU>
<TI>Traumatic brain tissue acidosis : experimental and clinical studies</TI>
<SO>Acta neurochirurgica. Supplementum</SO>
<YR>1993</YR>
<VL>57</VL>
<PG>160-4</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1993135012"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Muizelaar JP, Marmarou A, Ward J, Kontos HA, Choi SC, Becker DP, Gruemer H, Young H. Adverse effects of prolonged hyperventiliation in patients with severe head injury: a randomized clinical trial. J Neurosurg 1991; 75:731-739.&lt;/p&gt;" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Muizelaar JP, Marmarou A, Ward J, Kontos HA, Choi SC, Becker DP et al</AU>
<TI>Adverse effects of prolonged hyperventiliation in patients with severe head injury: a randomized clinical trial</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1991</YR>
<VL>75</VL>
<PG>731-9</PG>
<IDENTIFIERS>
<IDENTIFIER TYPE="MEDLINE" VALUE="1992014242"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Ward JD, Choi A, Marmarou R, Moulton JP, Muizelaar A, DeDalles A, Becker DP, Kontos HA, Yount HF. Effect of prophylactic hyperventilation on outcome in patients with severe head injury. Hoff Eds. In Intracranial Pressure VII. Eds JT Hoff and AL Betz. Springer-Verlag. Berlin. Heidelberg. 1989.&lt;/p&gt;" PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Ward JD, Choi A, Marmarou R, Moulton JP, Muizelaar A, DeDalles A et al</AU>
<TI>Effect of prophylactic hyperventilation on outcome in patients with severe head injury</TI>
<SO>Intracranial Pressure</SO>
<YR>1989</YR>
<VL>VII</VL>
<ED>Hoff JT, Betz AL</ED>
<PB>Springer-Verlag</PB>
<CY>Berlin</CY>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES>
<STUDY DATA_SOURCE="PUB" ID="STD-Kerr-1997" NAME="Kerr 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kerr ME, Rudy EB, Weber BB, Stone KS, Turner BS, Orndoff PA et al</AU>
<TI>Effect of short-duration hyperventilation during endotracheal suctioning on intracranial pressure in severe head-injured adults</TI>
<SO>Nursing Research</SO>
<YR>1997</YR>
<VL>46</VL>
<NO>4</NO>
<PG>195-201</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marion-2002" NAME="Marion 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marion DW, Puccio A, Wisniewski SR, Kochanek P, Dixon CE, Bullian L et al</AU>
<TI>Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury</TI>
<SO>Critical Care Medicine</SO>
<YR>2002</YR>
<VL>30</VL>
<NO>12</NO>
<PG>2619-25</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Previgliano-2002" NAME="Previgliano 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Previgliano IJ, Ripoll PI, Chiappero G, Galindez, Germani L, Gonzalez DH et al</AU>
<TI>Optimizing Cerebral Perfusion Pressure During Fiberoptic Bronchoscopy in Severe Head Injury: Effect of Hyperventilation</TI>
<SO>Acta neurochirurgica</SO>
<YR>2002</YR>
<VL>[Suppl] 81</VL>
<PG>103-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Robertson-1999" NAME="Robertson 1999" YEAR="1999">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Robertson CS, Valadka AB, Hannay J, Contant CF, Gopinath SP, Cormio M et al</AU>
<TI>CPP/ICP Clinical Trial</TI>
<SO>www.emn-neurotrauma.de/tenerife_book/047emn99.pdf</SO>
<YR>1999</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Robertson CS, Valadka AB, Hannay J, Contant CF, Gopinath SP, Cormio M et al</AU>
<TI>Prevention of secondary ischemic insults after severe head injury</TI>
<SO>Critical Care Medicine</SO>
<YR>1999</YR>
<VL>27</VL>
<NO>10</NO>
<PG>2086-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2009-05-12 16:49:34 +0100" MODIFIED_BY="Emma M Sydenham">
<ADDITIONAL_REFERENCES MODIFIED="2009-05-12 16:49:34 +0100" MODIFIED_BY="Emma M Sydenham">
<REFERENCE ID="REF-Alexander-1992" MODIFIED="2009-05-12 16:49:34 +0100" MODIFIED_BY="Emma M Sydenham" NAME="Alexander 1992" TYPE="JOURNAL_ARTICLE">
<AU>Alexander E Jr</AU>
<TI>Global Spine and Head Injury Prevention Project (SHIP) [Editorial]</TI>
<SO>Surgical neurology</SO>
<YR>1992</YR>
<VL>38</VL>
<PG>478-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Becker-1985" MODIFIED="2008-06-09 23:28:05 +0100" MODIFIED_BY="[Empty name]" NAME="Becker 1985" TYPE="BOOK_SECTION">
<AU>Becker DP, Gardner S</AU>
<TI>Intensive management of head injury</TI>
<SO>Neurosurgery</SO>
<YR>1985</YR>
<VL>2</VL>
<PG>1593-9</PG>
<ED>Wilkins RH, Rengachary SS</ED>
<PB>McGraw-Hill</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bruce-1981" MODIFIED="2008-06-09 23:28:03 +0100" MODIFIED_BY="[Empty name]" NAME="Bruce 1981" TYPE="JOURNAL_ARTICLE">
<AU>Bruce DA, Alavi A, Bilaniuk L, Dolinskas C, Obrist W, Uzzell B</AU>
<TI>Diffuse cerebral swelling following head injuries in children: the syndrome of malignant brain oedema</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1981</YR>
<VL>54</VL>
<PG>170-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ghajar-1995" MODIFIED="2008-06-09 23:27:57 +0100" MODIFIED_BY="[Empty name]" NAME="Ghajar 1995" TYPE="JOURNAL_ARTICLE">
<AU>Ghajar J, Hariri RJ, Narayan RK, Iacono LA, Firlik K, Patterson RH</AU>
<TI>Survey of critical care management of comatose, head-injured patients in the United States</TI>
<SO>Critical Care Medicine</SO>
<YR>1995</YR>
<VL>23</VL>
<NO>3</NO>
<PG>560-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2009-05-05 15:53:58 +0100" MODIFIED_BY="Emma M Sydenham" NAME="Higgins 2008" TYPE="JOURNAL_ARTICLE">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>
<I>Cochrane Handbook for Systematic Reviews of Interventions</I> Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org</TI>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Jeevaratnam-1996" MODIFIED="2008-06-09 23:27:55 +0100" MODIFIED_BY="[Empty name]" NAME="Jeevaratnam 1996" TYPE="JOURNAL_ARTICLE">
<AU>Jeevaratnam DR, Menon DK</AU>
<TI>Survey of intensive care of severely head injured patients in the United Kingdom</TI>
<SO>BMJ</SO>
<YR>1996</YR>
<VL>312</VL>
<PG>994-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marion-1995" MODIFIED="2008-06-09 23:27:53 +0100" MODIFIED_BY="[Empty name]" NAME="Marion 1995" TYPE="JOURNAL_ARTICLE">
<AU>Marion DW, Darby JM</AU>
<TI>Hyperventilation and head injury [letter]</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1995</YR>
<VL>83</VL>
<NO>6</NO>
<PG>1113-4; discussion 1115-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marmarou-1993" MODIFIED="2009-05-05 15:54:40 +0100" MODIFIED_BY="Emma M Sydenham" NAME="Marmarou 1993" TYPE="JOURNAL_ARTICLE">
<AU>Marmarou A, Holdaway R, Ward JD, Yoshida K, Choi SC, Muizelaar JP et al</AU>
<TI>Traumatic brain tissue acidosis: experimental and clinical studies</TI>
<SO>Acta neurochirurgica. Supplementum</SO>
<YR>1993</YR>
<VL>57</VL>
<PG>160-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Marshall-1987" MODIFIED="2008-06-09 23:27:42 +0100" MODIFIED_BY="[Empty name]" NAME="Marshall 1987" TYPE="BOOK_SECTION">
<AU>Marshall LF, Marshall S</AU>
<TI>Medical management of intracranial pressure</TI>
<SO>Head Injury</SO>
<YR>1987</YR>
<PG>177-96</PG>
<EN>2</EN>
<ED>Cooper PR</ED>
<PB>Williams &amp; Wilkins</PB>
<CY>Baltimore</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Miller-1994" MODIFIED="2009-05-12 16:42:37 +0100" MODIFIED_BY="Emma M Sydenham" NAME="Miller 1994" TYPE="JOURNAL_ARTICLE">
<AU>Miller DJ</AU>
<TI>Swelling and blood flow in the injured child's brain [commentary]</TI>
<SO>Lancet</SO>
<YR>1994</YR>
<VL>44</VL>
<PG>421-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Previgliano-1995" MODIFIED="2008-06-09 23:27:40 +0100" MODIFIED_BY="[Empty name]" NAME="Previgliano 1995" TYPE="JOURNAL_ARTICLE">
<AU>Previgliano IJ</AU>
<TI>Hyperventilation and head injury [letter]</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1995</YR>
<VL>83</VL>
<NO>6</NO>
<PG>1112-3; discussion 1115-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Rosner-1995" MODIFIED="2008-06-09 23:27:38 +0100" MODIFIED_BY="[Empty name]" NAME="Rosner 1995" TYPE="JOURNAL_ARTICLE">
<AU>Rosner MJ</AU>
<TI>Hyperventilation and head injury [letter]</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1995</YR>
<VL>83</VL>
<NO>6</NO>
<PG>1113; discussion 1115-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sheinberg-1992" MODIFIED="2008-06-09 23:27:34 +0100" MODIFIED_BY="[Empty name]" NAME="Sheinberg 1992" TYPE="JOURNAL_ARTICLE">
<AU>Sheinberg M, Kanter MJ, Robertson CS, Contant CF, Narayan RK, Grossman RG</AU>
<TI>Continuous monitoring of jugular venous oxygen saturatoin in head injured patients</TI>
<SO>Journal of Neurosurgery</SO>
<YR>1992</YR>
<VL>76</VL>
<PG>212-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Task-force-1995" MODIFIED="2008-06-09 23:27:32 +0100" MODIFIED_BY="[Empty name]" NAME="Task force 1995" TYPE="BOOK">
<AU>Task force of the American Association of Neurological Surgeons and Joint Section in Neurotrauma and Critical Care</AU>
<SO>Guidelines for the management of severe head injury</SO>
<YR>1995</YR>
<PB>Brain Trauma Foundation</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ward-1989" MODIFIED="2008-06-09 23:27:29 +0100" MODIFIED_BY="[Empty name]" NAME="Ward 1989" TYPE="BOOK_SECTION">
<AU>Ward JD, Choi A, Marmarou R, Moulton JP, Muizelaar A, DeDalles A et al</AU>
<TI>Effect of prophylactic hyperventilation on outcome in patients with severe head injury</TI>
<SO>Intracranial Pressure VII</SO>
<YR>1989</YR>
<ED>Hoff JT, Betz AL</ED>
<PB>Springer-Verlag</PB>
<CY>Berlin, Heidlberg</CY>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2009-05-05 15:56:22 +0100" MODIFIED_BY="Emma M Sydenham">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2009-05-05 15:56:22 +0100" MODIFIED_BY="Emma M Sydenham" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR STUDY_ID="STD-Muizelaar-1991">
<CHAR_METHODS>
<P>Participants were stratified into two groups according to motor score of the GCS, and then randomised to a control group (n = 41), a hyperventilation group (n = 36) and a hyperventilation-plus-THAM group (n = 36). All patients received standard care, which included monitoring of ICP, and the introduction of various ICP lowering agents, such as mannitol and barbiturates. All patients were intubated and artificially ventilated. Not all patients necessarily had raised ICP at entry to the study; approximately 14% in each group had elevated ICP on admission. Therefore the study was testing a policy of prophylactic hyperventilation.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Participants with severe closed head injury (GCS &lt; or equal to 8), three years of age or older, who had already received initial resuscitation, diagnosis and treatment for mass lesions. Approximately 70% of the participants were male and most were young adults.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>The intervention in the hyperventilation and in the hyperventilation-plus-THAM group comprised adjusting the respiratory rate and the volume of the ventilator to keep PaCO2 at 24 to 28mmHg. In addition, the hyperventilation-plus-THAM group received an initial dose of THAM calculated individually according to body weight and base deficit. This was followed by a constant infusion of THAM at 1ml/kg/hr for five days. Hyperventilation was maintained for five days. The control group received only standard care, which included monitoring of ICP, and various ICP lowering agents such as mannitol and barbiturates.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>The authors presented outcomes of death, severe disability/vegetative state and good recovery/moderate disability at 3, 6 and 12 months stratified by motor score at time of entry. Follow up was 100%.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Kerr-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Intervention not eligible.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Marion-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non-randomised trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Previgliano-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Hyperventilation was only used for preventing an increase in ICP during bronchoscopy.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Robertson-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Both study groups received hyperventilation.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2009-05-05 15:56:22 +0100" MODIFIED_BY="Emma M Sydenham">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2009-05-05 15:56:22 +0100" MODIFIED_BY="Emma M Sydenham" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-05-05 15:56:22 +0100" MODIFIED_BY="Emma M Sydenham" RESULT="YES" STUDY_ID="STD-Muizelaar-1991">
<DESCRIPTION>
<P>Adequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2009-05-12 16:50:17 +0100" MODIFIED_BY="Emma M Sydenham">
<COMPARISON ID="CMP-001" MODIFIED="2009-05-12 16:50:01 +0100" MODIFIED_BY="Emma M Sydenham" NO="1">
<NAME>Hyperventilation versus Control</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.485727998179274" CI_START="0.36078822228712293" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7321428571428571" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.17193930760594373" LOG_CI_START="-0.44274764817887363" LOG_EFFECT_SIZE="-0.13540417028646493" METHOD="MH" MODIFIED="2009-05-12 16:49:55 +0100" MODIFIED_BY="Emma M Sydenham" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.3878694163014088" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="36" TOTAL_2="41" WEIGHT="100.0" Z="0.8634876488607435">
<NAME>Death</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="1.485727998179274" CI_START="0.36078822228712293" EFFECT_SIZE="0.7321428571428571" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="14" LOG_CI_END="0.17193930760594373" LOG_CI_START="-0.44274764817887363" LOG_EFFECT_SIZE="-0.13540417028646493" ORDER="4703" O_E="0.0" SE="0.3610701605775057" STUDY_ID="STD-Muizelaar-1991" TOTAL_1="36" TOTAL_2="41" VAR="0.13037166085946575" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.5793799453467852" CI_START="0.8212513430071255" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1388888888888888" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="25" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.19848661912688345" LOG_CI_START="-0.08552390722198701" LOG_EFFECT_SIZE="0.05648135595244821" METHOD="MH" MODIFIED="2009-05-12 16:50:01 +0100" MODIFIED_BY="Emma M Sydenham" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.4356507419321609" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="36" TOTAL_2="41" WEIGHT="100.0" Z="0.779558595154343">
<NAME>Death or severe disability</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="1.5793799453467852" CI_START="0.8212513430071255" EFFECT_SIZE="1.1388888888888888" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="25" LOG_CI_END="0.19848661912688345" LOG_CI_START="-0.08552390722198701" LOG_EFFECT_SIZE="0.05648135595244821" ORDER="4704" O_E="0.0" SE="0.16682918905210561" STUDY_ID="STD-Muizelaar-1991" TOTAL_1="36" TOTAL_2="41" VAR="0.0278319783197832" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2009-05-12 16:50:17 +0100" MODIFIED_BY="Emma M Sydenham" NO="2">
<NAME>Hyperventilation plus THAM versus Control</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.7150438334579174" CI_START="0.4668923805852011" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8948412698412699" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="14" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.23427522431209719" LOG_CI_START="-0.3307832134472268" LOG_EFFECT_SIZE="-0.04825399456756474" METHOD="MH" MODIFIED="2009-05-12 16:50:11 +0100" MODIFIED_BY="Emma M Sydenham" NO="1" P_CHI2="1.0" P_Q="0.0" P_Z="0.7378151887190301" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="36" TOTAL_2="41" WEIGHT="100.0" Z="0.3347480017735837">
<NAME>Death</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="1.7150438334579174" CI_START="0.4668923805852011" EFFECT_SIZE="0.8948412698412699" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="14" LOG_CI_END="0.23427522431209719" LOG_CI_START="-0.3307832134472268" LOG_EFFECT_SIZE="-0.04825399456756474" ORDER="4705" O_E="0.0" SE="0.3319181234242046" STUDY_ID="STD-Muizelaar-1991" TOTAL_1="36" TOTAL_2="41" VAR="0.11016964065744553" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.0461858710787483E-31" CI_END="1.2838635439534694" CI_START="0.5835405353485441" CI_STUDY="95" CI_TOTAL="95" DF="0.0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8655555555555556" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="25" I2="100.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="0.1085188669904126" LOG_CI_START="-0.2339289705239333" LOG_EFFECT_SIZE="-0.06270505176676038" METHOD="MH" MODIFIED="2009-05-12 16:50:17 +0100" MODIFIED_BY="Emma M Sydenham" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.4728982153694997" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="36" TOTAL_2="41" WEIGHT="100.0" Z="0.7177714655968386">
<NAME>Death or severe disability</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<DICH_DATA CI_END="1.2838635439534691" CI_START="0.583540535348544" EFFECT_SIZE="0.8655555555555555" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="25" LOG_CI_END="0.10851886699041252" LOG_CI_START="-0.2339289705239334" LOG_EFFECT_SIZE="-0.06270505176676043" ORDER="4706" O_E="0.0" SE="0.20115555490006143" STUDY_ID="STD-Muizelaar-1991" TOTAL_1="36" TOTAL_2="41" VAR="0.040463557267151624" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2009-05-06 14:40:13 +0100" MODIFIED_BY="Karen Blackhall">
<APPENDIX ID="APP-01" MODIFIED="2009-05-06 14:37:33 +0100" MODIFIED_BY="Karen Blackhall" NO="1">
<TITLE MODIFIED="2008-06-09 23:25:05 +0100" MODIFIED_BY="[Empty name]">Search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2009-05-06 14:37:33 +0100" MODIFIED_BY="Karen Blackhall">
<P>
<B>This MEDLINE search strategy was used and adapted, as appropriate, for each of the other databases:CENTRAL (The Cochrane Library), MEDLINE, EMBASE, National Research Register and Web of Science.</B>
</P>
<P>#1explode "Craniocerebral trauma" / all SUBHEADINGS<BR/>#2 explode "Intracranial-Pressure" / all SUBHEADINGS<BR/>#3 (brain near injur*) or (head near injur*) or (brain near trauma*) or (head near trauma*)<BR/>#4 intracranial pressure<BR/>#5 #1 or #2 or #3 or #4<BR/>#6 explode "Respiration-Artificial" / all SUBHEADINGS<BR/>#7 hyperventilat*<BR/>#8 (carbon dioxide near level*) or (CO<SUB>2</SUB> near level*)<BR/>#9 PaCO<SUB>2</SUB>
<BR/>#10 #6 or #7 or #8 or #9<BR/>#11 RCT filter (Clarke 2001)<BR/>#12 #5 and #10 and #11</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2009-05-06 14:40:13 +0100" MODIFIED_BY="Karen Blackhall" NO="2">
<TITLE MODIFIED="2009-05-06 14:40:13 +0100" MODIFIED_BY="Karen Blackhall">Search strategies: 2008 update</TITLE>
<APPENDIX_BODY MODIFIED="2009-05-06 14:38:25 +0100" MODIFIED_BY="Karen Blackhall">
<P>
<B>CENTRAL (The Cochrane Library 2007, Issue 4)</B>
<BR/>#1MeSH descriptor Craniocerebral Trauma explode all trees<BR/>#2MeSH descriptor Cerebrovascular Trauma explode all trees<BR/>#3MeSH descriptor Brain Edema explode all trees<BR/>#4(brain or cerebral or intracranial) near3 (oedema or edema or swell*)<BR/>#5MeSH descriptor Glasgow Coma Scale explode all trees<BR/>#6MeSH descriptor Glasgow Outcome Scale explode all trees<BR/>#7MeSH descriptor Unconsciousness explode all trees<BR/>#8glasgow near3 (coma or outcome) near3 (score or scale)<BR/>#9(Unconscious* or coma* or concuss* or 'persistent vegetative state') near 3 (injur* or trauma* or damag* or wound* or fracture*)<BR/>#10"Rancho Los Amigos Scale"<BR/>#11(head or crani* or cerebr* or capitis or brain* or forebrain* or skull* or hemispher* or intra-cran* or inter-cran*) near3 (injur* or trauma* or damag* or wound* or fracture* or contusion*)<BR/>#12Diffuse near3 axonal near3 injur*<BR/>#13(head or crani* or cerebr* or brain* or intra-cran* or inter-cran*) near3 (haematoma* or hematoma* or haemorrhag* or hemorrhag* or bleed* or pressure)<BR/>#14(#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13)<BR/>
<BR/>
<B>PubMed [www.ncbi.nlm.nih.gov/sites/entrez/] (searched 7 Jan 2008 (added to PubMed in the last 60 days)</B>
<BR/>#1Craniocerebral Trauma [mh] OR Brain Edema [mh] OR Glasgow Coma Scale [mh] OR Glasgow Outcome Scale [mh] OR Unconsciousness [mh] OR Cerebrovascular Trauma [mh] OR ((head OR cranial OR cerebral OR brain* OR intra-cranial OR inter-cranial) AND (haematoma* OR hematoma* OR haemorrhag* OR hemorrhage* OR bleed* OR pressure)) OR (Glasgow AND scale) OR ("diffuse axonal injury" OR "diffuse axonal injuries") OR ("persistent vegetative state") OR ((unconscious* OR coma* OR concuss*) AND (injury* OR injuries OR trauma OR damage OR damaged OR wound* OR fracture* OR contusion* OR haematoma* OR hematoma* OR haemorrhag* OR hemorrhag* OR bleed* OR pressure))<BR/>#2(randomised OR randomized OR randomly OR random order OR random sequence OR random allocation OR randomly allocated OR at random OR randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized controlled trials [mh]) NOT ((models, animal[mh] OR Animals[mh] OR Animal Experimentation[mh] OR Disease Models, Animal[mh] OR Animals, Laboratory[mh]) NOT (Humans[mh]))<BR/>#3Search #1 AND #2 Limits: published in the last 60 days<BR/>
<BR/>
<B>MEDLINE (Ovid SP) 1950 to Nov (week 2) 2007</B>
<BR/>1.exp Craniocerebral Trauma/<BR/>2.exp Brain Edema/<BR/>3.exp Glasgow Coma Scale/<BR/>4.exp Glasgow Outcome Scale/<BR/>5.exp Unconsciousness/<BR/>6.exp Cerebrovascular Trauma/<BR/>7.((head or crani$ or cerebr$ or capitis or brain$ or forebrain$ or skull$ or hemispher$ or intra-cran$ or inter-cran$) adj3 (injur$ or trauma$ or damag$ or wound$ or fracture$ or contusion$)).ab,ti.<BR/>8.((head or crani$ or cerebr$ or brain$ or intra-cran$ or inter-cran$) adj3 (haematoma$ or hematoma$ or haemorrhag$ or hemorrhag$ or bleed$ or pressure)).ti,ab.<BR/>9.(Glasgow adj3 (coma or outcome) adj3 (scale$ or score$)).ab,ti.<BR/>10."rancho los amigos scale".ti,ab.<BR/>11.("diffuse axonal injury" or "diffuse axonal injuries").ti,ab.<BR/>12.((brain or cerebral or intracranial) adj3 (oedema or edema or swell$)).ab,ti.<BR/>13.((unconscious$ or coma$ or concuss$ or 'persistent vegetative state') adj3 (injur$ or trauma$ or damag$ or wound$ or fracture$)).ti,ab.<BR/>14.or/1-13<BR/>15. (randomised or randomized or randomly or random order or random sequence or random allocation or randomly allocated or at random or controlled clinical trial$).tw,hw.<BR/>16.clinical trial.pt.<BR/>17.randomized controlled trial.pt.<BR/>18.17 or 18 or 19<BR/>19.exp models, animal/<BR/>20.exp Animals/<BR/>21.exp Animal Experimentation/<BR/>22.exp Disease Models, Animal/<BR/>23.exp Animals, Laboratory/<BR/>24.or/21-25<BR/>25.Humans/<BR/>26.20 not 25<BR/>27.18 not 26<BR/>28.14 and 27<BR/>29.2007$.ed.<BR/>30.28 and 29<BR/>
<BR/>
<B>EMBASE (Ovid SP) 1980 to (week 1) Jan 2008</B>
<BR/>1.exp Brain Injury/<BR/>2.exp Brain Edema/<BR/>3.exp Glasgow Coma Scale/<BR/>4.exp Glasgow Outcome Scale/<BR/>5.exp Rancho Los Amigos Scale/<BR/>6.exp Unconsciousness/<BR/>7.((brain or cerebral or intracranial) adj3 (oedema or edema or swell$)).ab,ti.<BR/>8.((head or crani$ or cerebr$ or capitis or brain$ or forebrain$ or skull$ or hemispher$ or intra-cran$ or inter-cran$) adj3 (injur$ or trauma$ or damag$ or wound$ or fracture$ or contusion$)).ab,ti.<BR/>9.(Glasgow adj3 (coma or outcome) adj3 (scale$ or score$)).ab,ti.<BR/>10.Rancho Los Amigos Scale.ab,ti.<BR/>11.((unconscious$ or coma$ or concuss$ or 'persistent vegetative state') adj3 (injur$ or trauma$ or damag$ or wound$ or fracture$)).ti,ab.<BR/>12.Diffuse axonal injur$.ab,ti.<BR/>13.((head or crani$ or cerebr$ or brain$ or intra-cran$ or inter-cran$) adj3 (haematoma$ or hematoma$ or haemorrhag$ or hemorrhag$ or bleed$ or pressure)).ab,ti.<BR/>14.or/1-13<BR/>15.exp animal model/<BR/>16.Animal Experiment/<BR/>17.exp ANIMAL/<BR/>18.exp Experimental Animal/<BR/>19.1 or 2 or 3 or 4<BR/>20.Human/<BR/>21.5 not 6<BR/>22.(randomised or randomized or randomly or random order or random sequence or random allocation or randomly allocated or at random or controlled clinical trial$).tw,hw.<BR/>23.exp clinical trial/<BR/>24.8 or 9<BR/>25.10 not 7<BR/>26.14 and 25<BR/>27.2007$.em.<BR/>28.26 and 27<BR/>
<BR/>
<B>PsycINFO (Ovid SP) 1806 to April 2007</B>
<BR/>1.explode "Head-Injuries" in MJ,MN<BR/>2.explode "Brain-Damage" in MJ,MN<BR/>3.explode "Traumatic-Brain-Injury" in MJ,MN<BR/>4.explode "Brain-Concussion" in MJ,MN<BR/>5.explode "Coma-" in MJ,MN<BR/>6.Unconscious* or coma* or concuss* or "persistent vegetative state"<BR/>7.(head or crani* or cerebr* or capitis or brain* or forebrain* or skull* or hemispher* or intra-cran* or inter-cran*) near (injur* or trauma* or damag* or wound* or fracture* or contusion*)<BR/>8.(head or crani* or cerebr* or brain* or intra-cran* or inter-cran*) near (haematoma* or hematoma* or haemorrhag* or hemorrhag* or bleed* or pressure)<BR/>9.#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8<BR/>
</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>